ASCO preview: Merck’s Keytruda, Novartis’ Kisqali face their moment of truth in early-stage cancers aliu Thu, 05/25/2023 – 14:31 More: ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers Source: fierce
read moreJohnson & Johnson takes another step in CAR-T race with Bristol Myers in multiple myeloma kdunleavy Thu, 05/25/2023 – 10:52 More: Johnson & Johnson takes another step in CAR-T race with Bristol Myers in multiple myeloma Source: fierce
read moreApellis scraps pegcetacoplan development in ALS after phase 2 trial flop zbecker Thu, 05/25/2023 – 10:42 More: Apellis scraps pegcetacoplan development in ALS after phase 2 trial flop Source: fierce
read moreAfter breakup with Otsuka, Akebia finds new partner for oral anemia drug in Europe aliu Thu, 05/25/2023 – 09:32 More: After breakup with Otsuka, Akebia finds new partner for oral anemia drug in Europe Source: fierce
read moreASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA? aliu Thu, 05/25/2023 – 08:25 More: ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade
read moreThe collaboration aims to develop novel preclinical models with a view to identifying new treatments More: Centre for Genomic Regulation and Almirall join forces on skin cancer treatments Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals